2m 2m 2m 2m 2m 2m 2m
Amphastar Pharma (AMPH)
NASDAQ
$19.35+$0.05 (+0.29%)
Price as of Jul 13, 2026 7:57 PM EDT- $825.4MMarket Cap
- -12.12%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Amphastar Pharma (AMPH)
$19.35+$0.05 (+0.29%)
AMPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.29 | ||
Change | +$0.57 (+3.04%) | ||
Open | $19.00 | ||
High | $19.68 | ||
Low | $18.95 | ||
Previous Close | $18.72 | ||
Volume | 384,539 | ||
30-Day Average Volume | 580,698 | ||
1-Week Change | -1.63% | ||
1-Month Change | -3.98% | ||
1-Year Change | -12.12% | ||
3-Year Change | -65.10% | ||
5-Year Change | -3.02% | ||
Fundamentals | |||
Shares Outstanding | 44.1M | ||
Total Assets | $1.6B | ||
Market Cap | $825.4M | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | $6.4M | ||
Free Cash Flow | $38.3M | ||
EBIT | $12.3M | ||
EBITDA | $18.5M | ||
Net Working Capital | $469.2M | ||
EPS | $0.14 | ||
Enterprise Value/EBITDA | 68 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 134 | ||
PEG | -2 | ||
Price/Free Cash Flow | 22 | ||
Price/Operating Cash Flow | 17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue